Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

RETHINK REFLUX Registry

NCT: NCT04253392 · ACTIVE_NOT_RECRUITING

NCT IDNCT04253392
StatusACTIVE_NOT_RECRUITING
Start Date2020-07-08
Completion2032-07-31
SponsorEthicon Endo-Surgery (INDUSTRY)
First posted
Last updated

Brief Summary

The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑